Rui Zhou

Dr. Rui Zhou

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2024 in Drug Design, Development and Therapy
Verified
Journal Article
Open access
PDF file
RZRui Zhou
Rui Zhou
LFLijuan Fu
Lijuan Fu
SLShu Liu
Shu Liu
SGSanjie Gao
Sanjie Gao
ZZZhifu Zhao
Zhifu Zhao
LXLize Xiong
Lize Xiong
Purpose: To compare the influences of propofol, ciprofol and remimazolam on dreaming during painless gastrointestinal endoscopy. Methods: This study was a single-center, prospective, parallel-design, double-blind, randomized clinical trial. Between May 2023 and October 2023, patients undergoing elective painless gastrointestinal endoscopy were recruited and randomly allocated into one of the three groups. Demographic data, intraoperative information, incidence of dreaming, insufficient anesthesia and intraoperative awareness, type of dream, patient satisfaction score, adverse events, and improvement of sleep quality were collected. Results: The difference in incidence of dreaming among the three groups was not significant (33.33% vs 48.33% vs 41.67%, p=0.061). The number of patients with intraoperative hypotension in the propofol group was larger than that of the remimazolam group (32 vs 12, p=0.001). However, the cases of intraoperative hypotension between propofol group and ciprofol group or ciprofol group and remimazolam group were comparable (32 vs 22, p=0.122; 22 vs 12, p=0.064). The percentage of insufficient anesthesia between propofol group and remimazolam group was significant (13.33% vs 1.67%, p=0.001), while no statistical difference was detected between propofol group and remimazolam group or ciprofol group and remimazolam group (13.33% vs 5.00%, p=0.025; 5.00% vs 1.67%, p=0.150). The ability of propofol to improve sleep quality at 1st post-examination day was significantly better than that of remimazolam (86.21% vs 72.88%, p=0.015), while it was not significant between propofol group and ciprofol group or ciprofol group and remimazolam group (86.21% vs 80.36%, p=0.236; 72.88% vs. 72.88%, p=0.181). Incidence of intraoperative awareness, intraoperative hypoxia, type of dream, satisfaction score, adverse events during recovery, and sleep improvement on the 7th post-examination day was not significant among the groups. Conclusion: Anesthesia with propofol, ciprofol and remimazolam, respectively, for gastrointestinal endoscopy did not induce statistical difference in the incidence of dreaming, despite that all of them are more likely to induce pleasant dreams.

1 May 2024 in Local and Regional Anesthesia
Verified
Journal Article
Open access
PDF file
RZRui Zhou
Rui Zhou
WJWencai Jiang
Wencai Jiang
QMQingyuan Miao
Qingyuan Miao
XLXinyang Li
Xinyang Li
LXLize Xiong
Lize Xiong
Purpose: Rebound pain after regional anesthesia, a common phenomenon when the analgesic effect wears off, has been recognized in the last a few years. The aim of this study is to analyze the status and tendency of this area in a macroscopic perspective. Methods: Bibliometric analysis is the primary methodology of this study. Literature retrieval was conducted in Web of Science (WoS) Core Collection. WoS, Excel, VOSviewer and CiteSpace were employed to do the analyses and visualization. Parameters were analyzed, such as publications, citations, journals, and keywords, etc. Results: In total, 70 articles in the past 10 years were identified eligible. Most articles (14 pieces) were published in 2021, followed by 2022 and 2023 with 13 articles. Researchers come from 134 institutions and 20 countries. Huang Jung-Taek, Hallym College, and USA are the most productive author, institution and country, respectively. The articles were mainly published on the top journals of anesthesiology, orthopedics and surgery. The topic of these articles is primarily about the clinical issues of rebound pain. Peripheral nerve block, brachial plexus block and femoral nerve block are the activist keywords in the area, while perioperative management, fracture surgery and outcome may become hotpots in the next years. Conclusion: Our results show that the study of rebound pain after regional anesthesia starts relatively late and is in upward tendency, future studies can focus on the perioperative management and outcomes of fracture patients, and the definition and mechanism of rebound pain after regional anesthesia.

1 June 2024 in Journal of Multidisciplinary Healthcare
Verified
Journal Article
Open access
PDF file
QMQingyuan Miao
Qingyuan Miao
RZRui Zhou
Rui Zhou
XLXinyang Li
Xinyang Li
LXLize Xiong
Lize Xiong
Objective: Postoperative delirium (POD), a common complication affecting short- and long-term prognosis in elderly patients, leads to a heavy burden on social economy and health care. The main purpose of this study is to conduct a bibliometric analysis of the 100 most frequently cited articles on POD. Methods: “Postoperative delirium” and its synonyms were searched in the Web of Science (WoS) core database. The top-100 cited articles were automatically selected by sorting the records in descending order. Key information such as author, journal, article type, publication year, citations, since 2013 usage count, institution, country, and keywords were extracted and analyzed. VOSviewer software was applied to do the visualization analyses of institution co-operation, author interaction, author co-citation, and keywords co-occurrence. The CiteSpace software was used to analyze keywords burst. Results: Most articles were published by authors and institutions in the United States of America (USA). Inouye was the most influential author of this field. The journals that recorded these articles had a high impact factor (IF), with a highest IF of 168.9 and an average IF of 18.04. Cohort studies were the main document type in this field (42 publications), followed by randomized controlled trial (RCT) and systematic reviews or meta-analysis (18 and 14, respectively). The 10 keywords with the highest appearance were “delirium”, “risk-factors”, “surgery”, “confusion assessment method”, “elderly patients”, “hip fracture”, “intensive care unit”, “cardiac surgery”, “general anesthesia”, and “risk”. Moreover, “double blind” and “cardiac surgery” were the most recent booming keywords. Conclusion: We indicated the current research status and tendency of POD by analyzing the 100 most influential articles on POD. The USA is the leader in this field. Prospective study is the preference for authors to cite. Cardiac surgery remains the primary research carrier and the hotspots in the near future may be double-blind studies.

18 December 2024 in World Journal of Orthopedics
Verified
Journal Article
Open access
WYWei-Lin Yang
Wei-Lin Yang
WJWen-Cai Jiang
Wen-Cai Jiang
YPYan-Hua Peng
Yan-Hua Peng
XZXian-Jie Zhang
Xian-Jie Zhang
RZRui Zhou
Rui Zhou
BACKGROUND Low back pain has become a global problem. Since many traditional Chinese therapies are helpful for low back pain, the current status of low back pain in China may provide some insights to this issue. AIM To demonstrate the disease burden of low back pain in China and the response of Chinese scholars to this issue. METHODS The burden of low back pain in China was estimated using the Global Burden of Disease Study 2021 released by the American Institute for Health Metrics and Evaluation. The incidence, prevalence and disability-adjusted life years were analyzed. We also performed a bibliometric analysis to analyzed the publication trend, changes of cooperation models and research topics on low back pain. RESULTS Prevalence of low back pain increased from 69.61 million in 1990 to 102.96 million in 2021. New cases increased by a stunning 44.50 million in 2021. Low back pain led to an increase of 4.16 per 1000000 population in terms of disability-adjusted life years from 1990 to 2021. But the increase in China was slower than that of world average. As a response, publications of low back pain published by Chinese scholars were stably raised. From 1990 to 2023, domestic cooperation significantly increased, while international cooperation and no cooperation decreased. However, domestic cooperation decreased between 2021 and 2023. The number of studies on prevention and treatment of low back pain reduced from 1990 to 2023, while the mechanism, etiology and other aspects of low back pain augmented. CONCLUSION The burden of low back pain in China is heavy. Together with the government, Chinese institutions of medical science should do more in declining the impacts of low back pain.

1 June 2025 in Drug Design, Development and Therapy
Verified
Journal Article
Open access
PDF file
WYWeilin Yang
Weilin Yang
RZRui Zhou
Rui Zhou
XZXinyu Zhou
Xinyu Zhou
XCXuemeng Chen
Xuemeng Chen
DZDan Zhou
Dan Zhou
XZXianjie Zhang
Xianjie Zhang
Objective: To determine the 50% effective dose (ED50) and 95% effective dose (ED95) of oliceridine in suppressing gastroscope insertion responses during painless gastroscopy when combined with 0.3 mg/kg remimazolam. Methods: This prospective study enrolled 52 patients scheduled for elective painless gastroscopy. The initial dose of oliceridine was 15 ug/kg, with sequential 1.5 ug/kg adjustments based on response. ED50 and ED95 were calculated using the modified Dixon’s up-and-down method and Probit regression analysis. Vital signs, adverse events, anesthesia induction time, recovery time, and satisfaction scores (patients, anesthesiologists, and endoscopists) were recorded. Results: When combined with 0.3 mg/kg remimazolam, the ED50 and ED95 of oliceridine for suppressing insertion responses were 12.717 ug/kg and 18.818 ug/kg, respectively. The time from drug administration to successful scope insertion was 2 (2, 3) minutes, and the recovery-to-discharge time was 21 (16.5, 22.5) minutes. Vital signs remained stable throughout the procedure, with no hypoxemia, hypotension, or arrhythmias. No anesthesia-related adverse events (eg, nausea, vomiting and dizziness) occurred. Satisfaction scores were high: 10 (10, 10) for patients, 10 (9, 10) for anesthesiologists, and 9 (8, 10) for endoscopists. Conclusion: Oliceridine combined with 0.3 mg/kg remimazolam effectively suppresses gastroscope insertion response at ED50 and ED95 doses of 12.717 ug/kg and 18.818 ug/kg, respectively. This optimized regimen provides hemodynamic stability, rapid recovery and high procedural satisfaction, with no observed adverse events. These findings support its clinical utility as a safe and efficient anesthetic protocol for painless gastroscopy. Trial Registration: Chinese Clinical Trial Registry (ChiCTR2400093416).

27 January 2026 in IBRO Neuroscience Reports
Verified
Journal Article
Open access
LFLijuan Fu
Lijuan Fu
WJWencai Jiang
Wencai Jiang
YPYanhua Peng
Yanhua Peng
XZXianjie Zhang
Xianjie Zhang
RZRui Zhou
Rui Zhou
While the degree of population aging is increasing, a nationwide stroke program was started in 2011. We analyzed how population aging outpaced gains in stroke care in China. The number of deaths, incidence, prevalence, Disability-Adjusted Life Years (DALYs) attributable to stroke and its subtypes from 2012 to 2021 were extracted from the Global Health Data Exchange database. The total populations of age groups in 2012 and 2021 were extracted from the National Bureau of Statistics of China. The Das Gupta Decomposition method was applied to identify the contributions of population growth, population aging, and the changes in the incidence, mortality, prevalence, and DALYs. From 2012–2021, the total stroke incidence increased by 38.4 % (from 2.95 to 4.09 million), deaths by 17.6 % (from 2.20 to 2.59 million), and prevalence by 34.2 % (from 19.62 to 26.34 million) in China. Decomposition analysis identified rapid population aging as the predominant driver, accounting for 78.1 % of the incidence increase and even exceeding the total death increase (197.6 %), overwhelming the benefits from improved stroke care. The stroke subtype profile shifted markedly, with ischemic stroke's share of incidence rising from 62 % to 68 % and deaths from 41 % to 46 %, while intracerebral hemorrhage's contribution declined. The escalating stroke burden in China is primarily driven by population aging, followed by population growth, creating a paradox where healthcare improvements are offset demographically. The epidemic is increasingly characterized by ischemic stroke, leading to a growing population of survivors requiring long-term care. This necessitates a paradigm shift in health policy from a focus solely on reducing acute mortality towards building cost-effective, integrated systems for lifelong stroke management, chronic care, and secondary prevention tailored for an aging society.